BIMEKIZUMAB IMPROVED KEY PATIENT-REPORTED SYMPTOMS OF AXIAL SPONDYLOARTHRITIS INCLUDING SPINAL PAIN AND FATIGUE: RESULTS FROM TWO PHASE 3 STUDIES

被引：0
|
作者：
Bird, Paul [1 ]
Mease, Philip J. [2 ,3 ]
Deodhar, Atul [4 ]
Dougados, Maxime [5 ]
Dubreuil, Maureen [6 ]
Magrey, Marina [7 ]
Marzo-Ortega, Helena [8 ]
Rudwaleit, Martin [9 ,10 ,11 ,12 ]
de la Loge, Christine [13 ]
Ellis, Alicia [14 ]
Fleurinck, Carmen [13 ]
Oortgiesen, Marga [14 ]
Taieb, Vanessa [15 ]
Gensler, Lianne S. [16 ]
机构：
[1] Univ New South Wales, Sydney, NSW, Australia
[2] St Joseph Hlth, Swedish Med Ctr Providence, Seattle, WA USA
[3] Univ Washington, Swedish Med Ctr Providence, Seattle, WA 98195 USA
[4] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[5] Hop Cochin, Dept Rheumatol, Paris, France
[6] Boston Univ, Sch Med, Dept Rheumatol, Boston, MA 02118 USA
[7] Case Western Reserve Univ, Univ Hosp Cleveland, Cleveland, OH 44106 USA
[8] Univ Leeds, Leeds Teaching Hosp NHS Trust & Leeds Inst Mol Me, NIHR Leeds Biomed Res Ctr, Leeds, W Yorkshire, England
[9] Univ Bielefeld, Klinikum Bielefeld, Bielefeld, Germany
[10] Klinikum Bielefeld, Bielefeld, Germany
[11] Charite, Berlin, Germany
[12] Univ Ghent, Ghent, Belgium
[13] UCB Pharma, Brussels, Belgium
[14] UCB Pharma, Raleigh, NC USA
[15] UCB Pharma, Colombes, France
[16] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
INTERNAL MEDICINE JOURNAL | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
ARA-P29
引用
收藏
页码：24 / 25
页数：2
相关论文
共 50 条
  • [1] Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies
    Mease, Philip J.
    Deodhar, Atul
    Dougados, Maxime
    Dubreuil, Maureen
    Magrey, Marina
    Marzo-Ortega, Helena
    Rudwaleit, Martin
    De la Loge, Christine
    Ellis, Alicia
    Fleurinck, Carmen
    Oortgiesen, Marga
    Taieb, Vanessa
    Gensler, Lianne
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 810 - 813
  • [2] Bimekizumab Treatment Improved Key Patient-Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain, Fatigue, and Morning Stiffness: 52-Week Results from Two Phase 3 Studies
    Mease, Philip J.
    Dougados, Maxime
    Dubreuil, Maureen
    Magrey, Marina Nighat
    Marzo-Ortega, Helena
    Rudwaleit, Martin
    de la Loge, Christine
    Fleurinck, Carmen
    Massow, Ute
    Taieb, Vanessa
    Deodhar, Atul
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 996 - 1000
  • [3] Sustained Improvements with Bimekizumab in Patient-Reported Symptoms of Axial Spondyloarthritis: 2-Year Results from Two Phase 3 Studies
    Marzo-Ortega, Helena
    Mease, Philip
    Dougados, Maxime
    Dubreuil, Maureen
    Magrey, Marina
    Rudwaleit, Martin
    D'Agostino, Maria Antonietta
    de la Loge, Christine
    Massow, Ute
    Taieb, Vanessa
    Voiniciuc, Diana
    Deodhar, Atul
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1209 - 1213
  • [4] Improved Pain, Morning Stiffness, and Fatigue With Bimekizumab in Axial Spondyloarthritis: Results From the Phase III BE MOBILE Studies
    Navarro-Compan, Victoria
    Rudwaleit, Martin
    Dubreuil, Maureen
    Magrey, Marina
    Marzo-Ortega, Helena
    Mease, Philip J.
    Walsh, Jessica A.
    Dougados, Maxime
    de la Loge, Christine
    Fleurinck, Carmen
    Massow, Ute
    Vaux, Thomas
    Taieb, Vanessa
    Deodhar, Atul
    JOURNAL OF RHEUMATOLOGY, 2025, 52 (02) : 23 - 32
  • [5] Improved Pain, Morning Stiffness, and Fatigue With Bimekizumab in Axial Spondyloarthritis: Results From the Phase III BE MOBILE Studies
    Navarro-Compan, Victoria
    Rudwaleit, Martin
    Dubreuil, Maureen
    Magrey, Marina
    Marzo-Ortega, Helena
    Mease, Philip J.
    Walsh, Jessica A.
    Dougados, Maxime
    de la Loge, Christine
    Fleurinck, Carmen
    Massow, Ute
    Vaux, Thomas
    Taieb, Vanessa
    Deodhar, Atul
    JOURNAL OF RHEUMATOLOGY, 2025, 52 (01) : 23 - 32
  • [6] Patient-Reported Symptoms Improved with Stringent Control of Swollen Joints in Patients with Psoriatic Arthritis: Results from Two Phase 3 Studies of Bimekizumab
    Husni, M. Elaine
    Mease, Philip
    Gladman, Dafna
    Ink, Barbara
    Lambert, Jeremy
    Healy, Patrick
    Gossec, Laure
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2996 - 2999
  • [7] Sustained improvements with bimekizumab in patientreported symptoms of axial spondyloarthritis: 2-year results from two phase 3 studies
    Marzo-Ortega, H.
    Mease, P. J.
    Dougados, M.
    Dubreuil, M.
    Magrey, M.
    Rudwaleit, M.
    D'Agostino, M. A.
    de la Loge, C.
    Fleurinck, C.
    Massow, U.
    Taieb, V
    Deodhar, A.
    SWISS MEDICAL WEEKLY, 2024, 154 : 34S - 34S
  • [8] BIMEKIZUMAB IMPROVED PHYSICAL FUNCTION AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS FROM TWO PHASE 3 STUDIES
    Nicholls, David
    Dubreuil, Maureen
    Gaffney, Karl
    Gensler, Lianne S.
    Kay, Jonathan
    Navarro-Compan, Victoria
    de la Loge, Christine
    Ellis, Alicia
    Fleurinck, Carmen
    Oortgiesen, Marga
    Taieb, Vanessa
    Deodhar, Atul
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 26 - 27
  • [9] BIMEKIZUMAB IMPROVES KEY SYMPTOMS, DISEASE ACTIVITY AND FUNCTION IN PATIENTS ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS UP TO WEEK 24: RESULTS FROM TWO PHASE 3 STUDIES
    Gaffney, Karl
    McKay, Neil
    Sengupta, Raj
    Fleurinck, Carmen
    de la Loge, Christine
    Massow, Ute
    Taieb, Vanessa
    Zhao, Sizheng Steven
    Marzo-Ortega, Helena
    RHEUMATOLOGY, 2023, 62
  • [10] Work Productivity Improved in Patients with Axial Spondyloarthritis Receiving Bimekizumab Treatment over 52 Weeks: Results from Two Phase 3 Studies
    Rudwaleit, Martin
    Navarro-Compan, Victoria
    Deodhar, Atul
    Dubreuil, Maureen
    Morup, Michael Frank
    Taieb, Vanessa
    de la Loge, Christine
    Fleurinck, Carmen
    Massow, Ute
    Vaux, Thomas
    Boonen, Annelies
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1020 - 1023
12345